PDT Partners’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
DCM
QF
GECH
PDT Partners's ATEX Position: Q1 2025 in Review
PDT Partners sold out of Anterix (ATEX) in Q1 2025, closing a stake of 9,293 shares — an estimated $285K sold.
PDT Partners first reported a position in ATEX in Q3 2015 and held it in 4 quarters. The position peaked at $830K in Q3 2015. 128 funds tracked by Wall St. Rank hold ATEX as of Q1 2025.
- PDT Partners reported no remaining Anterix position as of Q1 2025 after selling out during the quarter.
- PDT Partners sold 9,293 Anterix shares in Q1 2025, an estimated $285K.
- PDT Partners first reported a position in Anterix in Q3 2015 and held it in 4 quarters.
- PDT Partners's Anterix position peaked at $830K in Q3 2015.
- 128 funds tracked by Wall St. Rank held Anterix as of Q1 2025.
Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.